Nordson corporation announces agreement to acquire atrion corporation, a market leader in medical infusion and cardiovascular technologies

Westlake, ohio--(business wire)--nordson corporation (nasdaq: ndsn) today announced that it has entered into a definitive agreement to acquire atrion corporation (nasdaq: atri), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. this reflects a valuation of 15x atrion's 2024 full-year estimated ebitda, inclusive of synergies nordson expects to generate in the first two years of its ownership. the acquisition expands nordson.
ATRI Ratings Summary
ATRI Quant Ranking